CCL2 and atherosclerosis: By modulating the oxidation of LDL, PON1 abolishes the oxidized LDL stimulated induction of monocyte-chemotactic protein-1 (MCP-1) production by endothelial cells, thereby preventing monocyte/endothelial cell interaction in one of the earliest processes of atherosclerosis [11,12].